“Valeant says it will eliminate as much as 15 per cent of its work force and move Bausch + Lomb's headquarters to New Jersey as part of its $8.7 billion acquisition,” reports Canadian Yahoo! News. “In a letter to workers, Valeant says that after the deal closes, it will eliminate between 10 per cent and 15 per cent of positions companywide. That works out to between 1,850 and 2,775 people. The Canadian drugmaker says it will remain based in Quebec, but it will move Bausch + Lomb's Rochester, N.Y. headquarters to New Jersey.” Read more.